Rhode Island Governor Dan McKee is warming to the idea of a tax on the wealthy as one way to bolster the state’s resources after a particularly turbulent year for its economy.
Only a handful of the top pharmas have signed Most Favored Nation drug pricing deals with the White House, while smaller biotechs continue to hang in limbo.